Showing 781-790 of 834 results for "".
- Staar Surgical Announces Agreement with Dr. Tobias Neuhann in Germany to Create Collaboration with Single Site Ophthalmology Clinicshttps://modernod.com/news/staar-surgical-announces-agreement-with-dr-tobias-neuhann-in-germany-to-create-collaboration-with-single-site-ophthalmology-clinics/2479798/Staar Surgical announced a multi-year strategic alliance agreement with Tobias Neuhann, MD, of the Augenklinik am Marienplatz (Eye Clinic at Marienplatz) in Munich, Germany. The agreement serves as a global partnership model for smaller and single site refractive surgery eye clinics that aim to p
- Chiropractic Treatment and Vision Loss: Examining the Connectionhttps://modernod.com/news/chiropractic-treatment-and-vision-loss-examining-the-connection/2479828/Many Americans visit chiropractors to address pain, often without informing their physicians. And they might not consider eye complications that could result, says Yannis Paulus, MD, a retina specialist at the University of Michigan Kellogg Eye Center. The energetic thrusts and rota
- Positive PEACHTREE Data to be Highlighted at Euretina 2018https://modernod.com/news/positive-peachtree-data-to-be-highlighted-at-euretina-2018/2479871/Clearside Biomedical announced that data from PEACHTREE, its pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be presented by Ron Neumann, MD, Uveitis Specialist at Maccabi Health Services, Tel Aviv, Israel and co-Chair of
- Clearside Biomedical to Present Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitishttps://modernod.com/news/clearside-biomedical-to-present-pivotal-phase-3-peachtree-clinical-trial-in-macular-edema-associated-with-non-infectious-uveitis/2479896/Clearside Biomedical announced that data from PEACHTREE, its pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macular edema associated with non-infectious uveitis, will be presented by Rahul N. Khurana, MD, an investigator for PEACHTREE, Partner at Northern California Retina Vitreo
- Clearside Biomedical Phase 3 PEACHTREE Trial Results Presented at ASRShttps://modernod.com/news/clearside-biomedical-phase-3-peachtree-trial-results-presented-at-asrs/2479980/Steven Yeh, MD, presented data from the phase 3 PEACHTREE trial at the American Society of Retina Specialists annual meeting as a late-breaking oral presentation. This was the first public presentation of data from PEACHTREE, a pivotal phase 3 trial of suprachoroidal CLS-TA in patients with macul
- “Dr. Robert Ritch Forum on Medicine of the Future” at World Ophthalmology Congress 2018https://modernod.com/news/dr-robert-ritch-forum-on-medicine-of-the-future-at-world-ophthalmology-congress-2018/2480090/Robert Ritch, MD, Distinguished Chair in Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai will host the “Robert Ritch Forum on Medicine of the Future” at the World Ophthalmology Congress 2018 (WOC2018) in Barcelona, Spain. This is the first time WOC is dedicating an entire fo
- FDA Commissioner Scott Gottlieb Proposes Modernization of FDA’s Drug Review Officehttps://modernod.com/news/fda-commissioner-scott-gottlieb-provides-statement-on-proposed-modernization-of-fdas-drug-review-office/2480120/FDA Commissioner Scott Gottlieb, MD, released a statement Monday outlining the agency’s position on a proposed modernization of FDA’s Drug Review Office. The statement reads: “Scientific and medical advances are giving the FDA more opportunities to more fully address diseases a
- Ivantis Announces Results of Comparative MIGS Clinical Trialhttps://modernod.com/news/ivantis-announces-results-of-comparative-migs-clinical-trial/2480238/Ivantis, developer of the Hydrus Microstent, announced the 12-month results of the COMPARE study for minimally invasive glaucoma surgery (MIGS). Results from the study will be presented by David Chang, MD, clinical professor of Ophthalmology at the University of California, San Francisco, during
- SERI Lugano: ParaCel Riboflavin Selected by FDA for Epi-on Cross-Linking for Keratoconushttps://modernod.com/news/seri-lugano-paracel-riboflavin-selected-by-fda-for-epi-on-cross-linking-for-keratoconus/2480255/The Switzerland Eye Research Institute has announced that the breakthrough transepithelial riboflavin formulation known as ParaCel, and based on the research of its CEO and Founder Roberto Pinelli, MD, has been selected among many others by the FDA for an epithelium-on corneal collagen cross-link
- Bio-Tissue to Present Webinar in 3-D Showcasing New Treatment Regimen to Diagnose and Treat Mechanical Dry Eyehttps://modernod.com/news/bio-tissue-to-present-webinar-in-3-d-showcasing-new-treatment-regimen-to-diagnose-and-treat-mechanical-dry-eye/2479188/Bio-Tissue announced today that it will present a special 3-D webinar on Wednesday, May 19, 2021, from 8:30 pm to 9:30 pm EDT, hosted by Neel Desai, MD, who will demonstrate his novel surgical technique known as Reservoir Restoration to treat Mechanical Dry Eye (MDE). He will also discuss how to